logo-loader

Full interview: Arcadia Biosciences CEO highlights GoodHemp and GoodWheat wins from letter to shareholders

Published: 14:44 30 Jan 2020 EST

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matthew Plavan tells Proactive that the company’s new USDA-compliant seed line called GoodHemp is shaping up into a strong revenue spinner with over $3 million in pre-season seed purchase commitments.

Plavan also discussed company goals and objectives for in 2020, Plavan saying he feels 'good about progress we've made getting out of the gate.'

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

34 minutes ago